Literature DB >> 17369852

SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1.

A-M F Jacobs1, S M Nicol, R G Hislop, E G Jaffray, R T Hay, F V Fuller-Pace.   

Abstract

The nuclear protein p68 (also known as Ddx5) is a prototypic member of the 'DEAD box' family of RNA helicases, which has been shown to be abnormally expressed and modified in colorectal tumors and to function as an important transcriptional regulator. Here, we show that p68 is modified in vivo on a single site (K53) by the small ubiquitin-like modifier-2 (SUMO-2). We demonstrate that the SUMO E3 ligase PIAS1 interacts with p68 and enhances its SUMO modification in vivo. To determine the functional consequences of SUMO modification, we compared the transcriptional activity of p68 and a K53R mutant that could not be SUMO-modified. Our data show that SUMO modification enhances p68 transcriptional repression activity and inhibits the ability of p68 to function as a coactivator of p53. These findings may be explained by the ability of wild type, but not K53R p68, to alter the modification state of chromatin by recruitment of histone deacetylase 1 (HDAC1).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369852     DOI: 10.1038/sj.onc.1210387

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

Review 1.  P68 RNA helicase as a molecular target for cancer therapy.

Authors:  Ting-Yu Dai; Liu Cao; Zi-Chen Yang; Ya-Shu Li; Li Tan; Xin-Ze Ran; Chun-Meng Shi
Journal:  J Exp Clin Cancer Res       Date:  2014-08-24

2.  The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells.

Authors:  Ramiro José González-Duarte; Verna Cázares-Ordoñez; Lorenza Díaz; Víctor Ortíz; Fernando Larrea; Euclides Avila
Journal:  Mol Cell Biochem       Date:  2015-08-28       Impact factor: 3.396

3.  Novel proteomics strategy brings insight into the prevalence of SUMO-2 target sites.

Authors:  Henri A Blomster; Ville Hietakangas; Jianmin Wu; Petri Kouvonen; Sampsa Hautaniemi; Lea Sistonen
Journal:  Mol Cell Proteomics       Date:  2009-02-24       Impact factor: 5.911

4.  Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.

Authors:  Vittoria Matafora; Alfonsina D'Amato; Silvia Mori; Francesco Blasi; Angela Bachi
Journal:  Mol Cell Proteomics       Date:  2009-07-12       Impact factor: 5.911

5.  Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.

Authors:  Etienne Dardenne; Sandra Pierredon; Keltouma Driouch; Lise Gratadou; Magali Lacroix-Triki; Micaela Polay Espinoza; Eleonora Zonta; Sophie Germann; Hussein Mortada; Jean-Philippe Villemin; Martin Dutertre; Rosette Lidereau; Stéphan Vagner; Didier Auboeuf
Journal:  Nat Struct Mol Biol       Date:  2012-09-30       Impact factor: 15.369

6.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

7.  Nuclear receptor, coregulator signaling, and chromatin remodeling pathways suggest involvement of the epigenome in the steroid hormone response of endometrium and abnormalities in endometriosis.

Authors:  Z Zelenko; L Aghajanova; J C Irwin; Linda C Giudice
Journal:  Reprod Sci       Date:  2011-12-02       Impact factor: 3.060

Review 8.  DEAD-box helicases as integrators of RNA, nucleotide and protein binding.

Authors:  Andrea A Putnam; Eckhard Jankowsky
Journal:  Biochim Biophys Acta       Date:  2013-02-15

9.  SUMOylation of nuclear actin.

Authors:  Wilma A Hofmann; Alessandro Arduini; Samantha M Nicol; Carlos J Camacho; James L Lessard; Frances V Fuller-Pace; Primal de Lanerolle
Journal:  J Cell Biol       Date:  2009-07-27       Impact factor: 10.539

10.  The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.

Authors:  N C Wortham; E Ahamed; S M Nicol; R S Thomas; M Periyasamy; J Jiang; A M Ochocka; S Shousha; L Huson; S E Bray; R C Coombes; S Ali; F V Fuller-Pace
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.